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Edited by Robert BaroukiAbstract Hypoxia inducible factor 1 is regulated by the
appearance of the HIF-1a subunit. HIF-1a is subjected to prote-
asomal destruction or enhanced protein translation, which re-
quires the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
We investigated how PI3K/Akt and glycogen synthase kinase
3b (GSK3b) aﬀect HIF-1a in human RKO cells under prolonged
periods of severe hypoxia/anoxia. 16- to 32-h lasting incubations
attenuated Akt activity and decreased HIF-1a protein. This was
reproduced by blocking PI3K with LY294002. GSK3b inhibition
by indirubins circumvented the eﬀect of hypoxia/anoxia or
LY294002 on HIF-1a. Ruling stability regulation of HIF-1a
protein and/or enhanced transcription of HIF-1a mRNA via
GSK3b inhibition out is suggestive for translational modulation
of HIF-1a under the inﬂuence of GSK3b.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Translation1. Introduction
Hypoxia inducible factor-1 (HIF-1) senses decreased oxygen
availability and responds with transcription of hypoxia-induc-
ible genes [1,2]. HIF-1 is composed of HIF-1a and HIF-1b
subunits [3] and the mRNA of both proteins is constitutively
expressed. However, under normoxia, HIF-1a protein is kept
at a low level by continuous degradation via the 26S-protea-
some, whereas HIF-1b protein is constitutively present. HIF-
prolyl hydroxylases sense oxygen and hydroxylate proline
402 and 564 within the oxygen-dependent degradation domain
of HIF-1a [4–6]. This allows binding of the von Hippel–Lin-
dau protein and subsequent degradation [7,8].
Translational regulation of HIF-1a during normoxia, e.g.,
by growth factors or cytokines, constitutes an alternative
regulatory circuit [1,9,10]. Enhanced expression of HIF-1a
is linked to the phosphatidylinositol 3-kinase (PI3K)/Akt/
FKBP-rapamycin-associated protein (FRAP; also known as
mammalian target of rapamycin, mTOR) pathway and/or
the mitogen-activated protein kinase pathway and is associ-
ated with phosphorylation of the translational regulatory
proteins 4E-BP1, p70S6 kinase and eukaryotic initiation fac-*Corresponding author. Fax +49 631 205 2492.
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mTOR cascade, which links growth promoting conditions
to translation.
Active PI3K phosphorylates and thus activates the down-
stream kinase Akt which in turn inhibits glycogen synthase ki-
nase 3b (GSK3b) via phosphorylation [12,13]. Cellular targets
of GSK3b comprise among others the eukaryotic initiation
factor (eIF) 2B, which becomes inactivated by phosphoryla-
tion at Ser535 of the e-subunit [14,15]. Recently, it has been
proposed that prolonged exposure to hypoxia activates
GSK3b and decreases HIF-1a protein [16]. This has been
attributed to inactivation and/or disappearance of Akt or acti-
vation of the forkhead transcription factor FOXO4 [17]
although details remain unknown.
To gain further insights of how GSK3b activity modulates
HIF-1a protein, we used a class of highly active indirubins,
characterized as GSK3b inhibitors [18–20], to show that
HIF-1a depletion under prolonged hypoxia/anoxia was re-
versed by GSK3b inhibition.2. Materials and methods
2.1. Materials
All chemicals were commercially available or as previously described
[21]. Speciﬁcally, the HIF-1a antibody was purchased from Becton
Dickinson (Heidelberg, Germany), the IkBa antibody came from San-
ta Cruz (Heidelberg, Germany), the Akt antibody, the phospho-Ser473
Akt antibody, and the phospho-Ser9 GSK3b antibody came from
Cell Signaling (Frankfurt, Germany), and the actin antibody from
Sigma (Steinheim, Germany). GSK3b-speciﬁc inhibitors, E232 (5-iod-
oindirubin-3 0-oxime) and E245 (5-methylindirubin-3 0-oxime), were
synthesized in the Department of Chemistry, Division of Food Chem-
istry and Environmental Toxicology, University of Kaiserslautern,
Germany.2.2. Cell culture
Human colon carcinoma cells (RKO) were cultured in Dulbeccos
modiﬁed Eagles medium with 4.5 g/l D-glucose. Medium was supple-
mented with 10% FCS, 2 mM glutamine, 100 U/ml penicillin, and
100 lg/ml streptomycin. Cells were transferred twice a week and med-
ium was changed prior to experiments. Cells were kept in a humidiﬁed
atmosphere of 5% CO2 in air at 37 C. Anoxic incubations (0% O2, 5%
CO2, and 95% N2) were carried out in a ﬂow-through manner in plexi-
glass chambers connected to a DIGAMIX 5KM 402 gas pump
(Woesthoﬀ, Bochum, Germany). Hypoxic incubations (0.1% O2, 5%
CO2, and 94.9% N2) were performed in an Invivo2 400 Working Sta-
tion (Ruskinn Technologies, Leeds, UK). For experiments, 1 · 106
cells were seeded in 10 cm dishes one day prior to experiments and
medium was changed before starting individual incubations. To avoid
reoxygenation, addition of reagents was done while preserving
hypoxia.blished by Elsevier B.V. All rights reserved.
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HIF-1a, IjBa, Akt, AktP(Ser473), GSK3bP(Ser9) and actin
were quantiﬁed by Western blot analysis as described in [21].
2.4. Quantitative real-time-PCR
Total RNA was isolated using the peqGOLD RNAPure kit. The re-
verse transcription (RT) was completed with an Advantage RT-for-
PCR kit using random hexamer primers. The following primer pairs
were selected for semi-quantitative real-time PCR:
HIF-1a forward 5 0-CTCAAAGTCGGACAGCCTCA-3 0
HIF-1a reverse 5 0-CCCTGCAGTAGGTTTCTGCT-3 0
actin forward 5 0 TGACGGGGTCACCCACACTGTGCCCATCTA-30
actin reverse 50-CTAGAAGCATTTGCGGTCGACGATGGAGGG-30.
Semi-quantitative real-time PCR was performed on a MyiQ Single-
Color Real-Time PCR Detection System using the Absolute SYBR
Green Fluorescein (Abgene, Hamburg, Germany).
2.5. Statistical analysis
Each experiment was performed at least three times and representa-
tive blots are shown.3. Results
3.1. GSK3b inhibitors reversed destruction of HIF-1a under
prolonged hypoxia/anoxia
To determine long lasting eﬀects of anoxia on HIF-1a
appearance and activation of the PI3K/Akt pathway, we ex-
posed human RKO cells for 4–24 h to anoxia. After 4 h of an-
oxia, HIF-1a was stabilized compared to a 24-h lasting
normoxic control (Fig. 1). HIF-1a accumulation became pro-
nounced at 8–16 h and started to decline at 24 h.
In parallel we followed phosphorylation, i.e., activation of
Akt by investigating Ser473 phosphorylation. Akt phosphory-
lation was induced under anoxia up to 8 h, thereafter decreas-
ing to normoxic values. Phosphorylation of Akt was veriﬁed
relative to the expression of Akt protein or the loading control
actin, which remained constant under anoxia. Phosphorylation
of GSK3b at Ser9, which is indicative of its inhibition, de-
creased in parallel to Akt dephosphorylation. Thus, transient
stabilization of HIF-1a by anoxia overlapped, at least in part,
with dephosphorylation of Akt and GSK3b.
To determine the role of GSK3b during HIF-1a disappear-
ance under prolonged periods of anoxia, we used recently de-
scribed GSK3b inhibitors chemically belonging to the class ofFig. 1. Expression of HIF-1a and activation of Akt during anoxia.
Expression of HIF-1a and Akt phosphorylation (AktP) at Ser473 as
well as GSK3b phosphorylation at Ser9 was time-dependently deter-
mined in RKO cells under anoxia relative to normoxia. Protein
amount of HIF-1a was compared to the expression of actin, whereas
phosphorylation of Akt and GSK3b was compared to the expression
of total Akt protein by Western blot analysis as described under
Section 2.indirubins. E232 was used based on its high potency as an
eﬀective GSK3b inhibitor determined in vitro [18]. Coincubat-
ing E232 under anoxia for 24 h prevented the disappearance of
HIF-1a. Increasing doses of 3–100 nM E232 allowed to re-
cover HIF-1a compared to the 8 h value (Fig. 2A).
Results obtained under anoxia were also seen under severe
hypoxia, i.e., with 0.1% oxygen (Fig. 2B). Hypoxia (8 h) stabi-
lized HIF-1a. This response was lost with prolonged incuba-
tion periods of 24 h. However, with increasing concentration
of E232, ranging from 3 to 100 nM, supplied in combination
with hypoxia, HIF-1a dose-dependently reappeared. E232 un-
der normoxia did not stabilize HIF-1a. We reproduced these
observations with a structurally related compound E245
(Fig. 2C). Again, anoxic destruction of HIF-1a was prevented
by E245. Although the overall response to hypoxia/anoxia in
combination with E232/E245 produces a similar outcome,
variations seen may be attributed to diﬀerent cell responses
to hypoxia vs. anoxia. Not observing caspase-3 activity at
any time (data not shown) ruled out cell death mechanisms
as an explanation for variations in HIF-1a stability regulation.
3.2. GSK3b inhibition aﬀects translation rather than HIF-1a
stabilization
Considering that Akt activity decreased under prolonged an-
oxia implies that inhibition of PI3K may produce similar ef-
fects. To prove this concept, we exposed RKO cells for 8 h
to anoxia, knowing that stabilization of HIF-1a is still evident
(Fig. 3). Adding 30 lM LY294002, an established PI3K inhib-
itor, in combination with anoxia largely eliminated the expres-
sion of HIF-1a.
Treatment with either E232 or E245 allowed to recover the
expression of HIF-1a, although PI3K was blocked. Thus,
pharmacological interference with PI3K activity or decreasingFig. 2. Inhibition of GSK3b reversed HIF-1a depletion. RKO cells
were exposed to either hypoxia or anoxia for 8 or 24 h in the presence
or absence of E232 or E245. HIF-1a expression was detected by
Western blot analysis compared to actin. For details see Section 2.
(A,B) HIF-1a expression was followed in response to anoxia or
hypoxia in the presence of E232. (C) HIF-1a expression was followed
in response to anoxia in the presence of E245.
Fig. 3. Blocking GSK3b attenuates HIF-1a depletion in response to
LY294002. RKO cells were exposed to anoxia for 8 h in the presence
or absence of LY294002 to block PI3K with the further addition of the
GSK3b inhibitors. LY294002 and GSK3b inhibitors were added
immediately prior to anoxic incubations. All shown proteins were
detected by Western blot analysis compared to actin. For details see
Section 2.
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HIF-1a, which is antagonized by blocking GSK3b. To exclude
that these eﬀects result from general inhibition of translation,
we followed expression of the control protein IjBa, known
for its rapid turnover. Neither inhibition of Akt phosphoryla-
tion by LY294002 nor GSK3b inhibitors aﬀected IjBa protein
levels.
We then determined whether E232 aﬀects the half-life of
HIF-1a as a potential mechanistic explanation for preserved
HIF-1a expression. Cells were exposed for 8 h to hypoxia
which resulted in HIF-1a stabilization. While continuing hy-
poxia, we added cycloheximide to block protein synthesis
and followed the disappearance of HIF-1a (Fig. 4). As ex-Fig. 4. Impact of GSK3b inhibition on HIF-1 protein stability under hypoxia
(CHX) was added and incubations continued under hypoxia for 1–4 h. The e
indicated, supplied prior to starting hypoxic exposures. Further details are a
Fig. 5. Impact of proteasome and/or GSK3b inhibition on HIF-1a expression
MG132 was added and incubations continued for 1–4 h. The experiment w
Further details are speciﬁed in Fig. 2.pected, HIF-1a was relatively stable under hypoxia and re-
vealed a half-life of roughly 2–3 h. Only at the 4 h time
point, HIF-1a became barely detectable.
Repeating this experiment in the presence of E232 to block
GSK3b showed no diﬀerence, suggesting that E232 does not
prolong the protein half-life of HIF-1a.
Next, we concentrated on HIF-1a destruction via the pro-
teasome. As seen before, 24 h incubations of RKO cells under
hypoxia eliminated HIF-1a expression. While continuing hyp-
oxic incubations, we supplied 5 lM MG132 for 1–4 h to block
the proteasome.
While MG132 did not restore HIF-1a level in untreated
cells, E232 pre-treated cells responded in that way (Fig. 5).
However, the combined actions of MG132 plus E232 did not
result in higher HIF-1a expression compared to E232 alone
(not shown). In conclusion, GSK3 neither aﬀected HIF-1a
protein half-life nor HIF-1a degradation. This suggests that
HIF-1a translation may be aﬀected. Interestingly, exposing
cells to MG132 under normoxic conditions resulted in a higher
HIF-1a level when co-treated with E232 as compared to
MG132 alone (Fig. 5).
To exclude transcriptional eﬀects, we examined HIF-1a
mRNA after GSK3b inhibition by E232.
As expected, E232 treatment under normoxia did not change
the amount of HIF-1a mRNA (Fig. 6). Incubations for 24 h
under hypoxia signiﬁcantly reduced HIF-1a mRNA but again,
E232 did not alter this eﬀect. These results add to our idea that
GSK3b inhibition enhances HIF-1a translation.4. Discussion
Our results suggest that prolonged periods of severe hypoxia/
anoxia in RKO cells caused HIF-1a to disappear. This
correlates with decreased Akt activity and was corroborated. RKO cells were exposed to hypoxia for 8 h. Thereafter, cycloheximide
xperiment was carried out either in the absence or presence of E232 as
s in Fig. 2.
. RKO cells were exposed to normoxia or hypoxia for 24 h. Thereafter,
as carried out either in the absence or presence of E232 as indicated.
Fig. 6. Inﬂuence of GSK3b inhibition on HIF-1a mRNA content.
RKO cells were either incubated under normoxia or hypoxia for 24 h
in the presence or absence of E232 as indicated. HIF-1a mRNA
content was analyzed by semi-quantitative real-time PCR relative to
normoxic controls. The HIF-1a mRNA content was normalized to
actin. Values represent means ± SD of three individual experiments.
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by indirubins under these conditions preserved, expression
of HIF-1a, an eﬀect unrelated to an extended HIF-1a pro-
tein half-life, proteasomal stability regulation or mRNA
appearance.
Recent understanding suggests that the lack of oxygen atten-
uates HIF-1a hydroxylation to stabilize HIF-1a [6]. Alterna-
tively, growth factors or cytokines increase HIF-1a
translation through a PI3K/Akt/mTOR-dependent pathway
[21–23]. Although several studies provided a link between
HIF-1a and Akt, HIF-1a does not appear to be a direct phos-
phorylation target of Akt. This implies that a downstream tar-
get of Akt such as GSK3b is involved in the expression
regulation of HIF-1a.
We see an active PI3K/Akt in RKO cells based on the detec-
tion of AktP (Ser473). Akt will phosphorylate GSK3b at
Ser9, keeping it inactive [15]. Culturing cells for long periods
under hypoxia/anoxia reduces phosphorylation, i.e., results
in inactivation of Akt, although the protein amount of Akt re-
mains constant. This corroborates an earlier study showing de-
creased Akt activity under prolonged hypoxia [22].
Unfortunately, as the authors noticed an overlapping disap-
pearance of total Akt in parallel to AktP (Ser473), changes
cannot exclusively be attributed to activity variations of Akt.
We provide supporting evidence that the disappearance of
HIF-1a indeed correlates with inactivation of Akt by blocking
PI3K, which is upstream of Akt, with LY294002. Although
inactivation of PI3K/Akt under prolonged hypoxia/anoxia
cannot be explained mechanistically, it goes along with the
observations that sustained hypoxia terminates protein synthe-
sis [24]. This is explained by hypophosphorylation of mTOR
and its eﬀectors 4E-BP1, p70S6 kinase, rpS6 and eIF4G [25].
As PI3K/Akt promotes phosphorylation of these translation
initiation factors, inactivation of Akt will attenuate protein
synthesis, aﬀecting among other proteins HIF-1a. Further-
more, inactivation of Akt causes activation of GSK3b which
phosphorylates and thereby inactivates eIF2B, another essen-
tial component aﬀecting protein synthesis [26,27]. The picture
emerges that prolonged hypoxia/anoxia downregulates the
activity of key factors involved in protein translation, thereby
eliminating HIF-1a expression. Under these conditions, inhibi-
tion of GSK3b restores HIF-1a protein. Indirubins used in ourexperiments have recently been described as powerful inhibi-
tors of GSK3b with IC50 values in the low nM range [18–
20]. In line, the unselective GSK3b inhibitor LiCl in the high
mM range has been reported to increase HIF-1a protein under
hypoxia, although the underlying mechanism remained un-
known [22]. Our study expands the existing knowledge by
excluding the possibility that inhibition of GSK3b aﬀects the
half-life of HIF-1a protein. Furthermore, the inability of
MG132 to accumulate HIF-1a under 24 h hypoxic incubations
indicates that the normal HIF-1a synthesis – degradation cycle
is not operating, because interference with proteasomal
destruction failed to stabilize the protein. Treatment with
indirubins restored the level of HIF-1a under long lasting hyp-
oxic incubations to a level comparable to short hypoxic incu-
bations of, e.g., 8 h. This implies that inhibition of GSK3b is
suﬃcient to restore HIF-1a proteins under prolonged hypox-
ia/anoxia. As regulation of protein stability was ruled out,
we conclude that GSK3b inhibition restores HIF-1a transla-
tion. We assume that blocking GSK3b relieves inhibition of
eIF2B, which in turn promotes HIF-1a translation. A similar
scenario is reported to contribute to skeletal myotubular
hypertrophy, where a dominant-negative GSK3b establishes
protein translation as a downstream target of the PI3K/Akt
pathway independent of mTOR [28]. As GSK3b normally acts
to inhibit the translation initiation factor eIF2B, blocking of
GSK3b as a result of Akt activation or by treatment with
indirubines might promote translation initiation and HIF-1a
synthesis. Our experiments point to an important role of
GSK3b in regulating HIF-1a translation, thus contributing
to HIF-1a protein regulation. Reconstitution of HIF-1a by
using GSK3b inhibitors under disease states associated with
long lasting periods of hypoxia/ischemia may turn out beneﬁ-
cial to reconstitute adaptive HIF-1-dependent responses.
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